JP2000503994A - 結腸腫瘍を抑制する方法 - Google Patents

結腸腫瘍を抑制する方法

Info

Publication number
JP2000503994A
JP2000503994A JP9527132A JP52713297A JP2000503994A JP 2000503994 A JP2000503994 A JP 2000503994A JP 9527132 A JP9527132 A JP 9527132A JP 52713297 A JP52713297 A JP 52713297A JP 2000503994 A JP2000503994 A JP 2000503994A
Authority
JP
Japan
Prior art keywords
compound
cancer
cells
colon cancer
estrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9527132A
Other languages
English (en)
Japanese (ja)
Inventor
ブランディ，マリア・エッレ
トネッリ，フランチェスコ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603150.5A external-priority patent/GB9603150D0/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of JP2000503994A publication Critical patent/JP2000503994A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
JP9527132A 1996-01-29 1997-01-27 結腸腫瘍を抑制する方法 Pending JP2000503994A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1077296P 1996-01-29 1996-01-29
GB9603150.5 1996-02-15
GB60/010,772 1996-02-15
GBGB9603150.5A GB9603150D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting colon tumors
PCT/US1997/002286 WO1997026877A1 (en) 1996-01-29 1997-01-27 Methods of inhibiting colon tumors

Publications (1)

Publication Number Publication Date
JP2000503994A true JP2000503994A (ja) 2000-04-04

Family

ID=26308709

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9527132A Pending JP2000503994A (ja) 1996-01-29 1997-01-27 結腸腫瘍を抑制する方法

Country Status (19)

Country Link
EP (1) EP0921799A4 (es)
JP (1) JP2000503994A (es)
KR (1) KR19990082054A (es)
CN (1) CN1209745A (es)
AR (1) AR010978A1 (es)
AU (1) AU707892B2 (es)
BR (1) BR9700778A (es)
CO (1) CO4761062A1 (es)
CZ (1) CZ235498A3 (es)
EA (1) EA001104B1 (es)
ID (1) ID15917A (es)
IL (1) IL125521A (es)
MX (1) MX9806036A (es)
NO (1) NO983451D0 (es)
NZ (1) NZ331105A (es)
PL (1) PL328147A1 (es)
TW (1) TW446560B (es)
WO (1) WO1997026877A1 (es)
YU (1) YU2397A (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
HUT71237A (en) * 1993-10-15 1995-11-28 Lilly Co Eli Pharmaceutical compositions for treating resistant neoplasms containing 2-phenyl-3-aroil-benzotiophene derivatives and process for their preparation
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
NO983451L (no) 1998-07-27
CO4761062A1 (es) 1999-04-27
NZ331105A (en) 2000-06-23
IL125521A (en) 2001-11-25
IL125521A0 (en) 1999-03-12
AR010978A1 (es) 2000-08-02
AU707892B2 (en) 1999-07-22
MX9806036A (es) 1998-11-29
CZ235498A3 (cs) 1999-02-17
EP0921799A4 (en) 2002-03-13
EA199800677A1 (ru) 1999-02-25
PL328147A1 (en) 1999-01-18
YU2397A (en) 1999-11-22
WO1997026877A1 (en) 1997-07-31
EP0921799A1 (en) 1999-06-16
KR19990082054A (ko) 1999-11-15
CN1209745A (zh) 1999-03-03
EA001104B1 (ru) 2000-10-30
BR9700778A (pt) 1998-10-06
AU2123997A (en) 1997-08-20
TW446560B (en) 2001-07-21
NO983451D0 (no) 1998-07-27
ID15917A (id) 1997-08-21

Similar Documents

Publication Publication Date Title
KR0161300B1 (ko) 뼈 손실 예방에 유용한 벤조티오펜
AU2018234903B2 (en) Combination therapies for the treatment of breast cancer
AU698389B2 (en) Methods for inhibiting LDL oxidation and atheroclerosis
PT652000E (pt) Metodos para a inibicao de angiogenese e doencas angiogenicas
BE1011382A5 (fr) Methodes de prevention du cancer du sein.
JPH11507371A (ja) メラノーマを阻止する方法
JP2000503994A (ja) 結腸腫瘍を抑制する方法
AU688112B2 (en) Methods of inhibiting endometrial cancer
US5843964A (en) Methods of inhibiting endometrial mitoses
JP2000503995A (ja) 筋腱膜線維腫（類腱腫）を抑制する方法
JPH10513470A (ja) Ｉｌ−６の効果を阻害する方法
US5670523A (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
JPH11501033A (ja) 子宮癌の阻止方法
JPH08253417A (ja) 脳又はｃｎｓのエストロゲン陽性腫瘍抑制用製剤
CA2244112A1 (en) Methods of inhibiting colon tumors
WO2023164776A1 (en) Oral pclx-001 in the treatment of human cancer
PT771201E (pt) Metodos para inibir a hiperplasia endometrica primaria
JPH03502806A (ja) ガンの処理
CA2244247A1 (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
MXPA97006520A (es) Metodos para inhibir el cancer de ovario
JPH08231395A (ja) 子宮類線維腫疾患抑制用製剤